Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2009
08/05/2009EP2083920A1 N-aryl-hydroxyalkylidene-carboxamide compounds and their use
08/05/2009EP2083844A2 Hcv ns3 protease inhibitors
08/05/2009EP2083840A1 Improved treatment for benign prostatic hyperplasia
08/05/2009EP2083834A2 Macrocyclic lactone compounds and methods for their use
08/05/2009EP2083833A2 Pharmaceutical anti-infective composition for inhalation.
08/05/2009EP2083832A1 Novel 1,4-benzothiepin-1,1-dioxide derivatives with improved properties, method for producing the same, drugs containing said compounds and use thereof
08/05/2009EP2083831A2 Method of treatment using fatty acid synthesis inhibitors
08/05/2009EP2083830A1 Improved methods of using phosphoantigen for the treatment of cancer
08/05/2009EP2083829A1 Use of phosphoenolpyruvate derivatives for treating necrosis of cardiac muscle tissue
08/05/2009EP2083828A1 A standardised extract and its use in the manufacture of a medicament
08/05/2009EP2083827A1 Use of estradiol valerate or 17 -estradiol in combination with dienogest for oral therapy for maintaining and/or increasing the female libido
08/05/2009EP2083825A1 Compositions for the treatment of hepatitis c and methods for using compositions for the treatment of hepatitis c
08/05/2009EP2083824A1 Methods for treating inflammatory conditions
08/05/2009EP2083823A2 Alcohol free formulation of argatroban
08/05/2009EP2083822A2 Substituted imidazoles as bombesin receptor subtype-3 modulators
08/05/2009EP2083821A1 Novel 4-amino-pyridine derivatives and their use as potassium channel modulators
08/05/2009EP2083820A1 Pharmaceutical compositions comprising intra- and extra- granular fractions
08/05/2009EP2083819A2 Pde10 inhibitors and related compositions and methods
08/05/2009EP2083818A2 Melatonin derivatives and their use as antioxidants
08/05/2009EP2083817A2 Method of restoring the incretin effect
08/05/2009EP2083816A2 Heterocyclic amide compounds useful as kinase inhibitors
08/05/2009EP2083814A1 Dmae as sole agent for the treatment of mild cognitive impairment
08/05/2009EP2083813A2 Nutrient sensor
08/05/2009EP2083812A1 Use of arginase inhibitors in the treatment of asthma and allergic rhinitis
08/05/2009EP2083811A1 Methods of treating mental retardation, down's syndrome, fragile x syndrome and autism
08/05/2009EP2083810A2 Compositions comprising carnosic acid 12-methylether
08/05/2009EP2083808A1 Use of buprenorphine or n-alkylated derivatives thereof for wound healing
08/05/2009EP2083807A2 Use of a combination of hypothermia inducing drugs
08/05/2009EP2083805A2 Use of tricyclic diterpenes and their derivatives for the treatment, co-treatment or prevention of inflammatory disorders and/or joint disorders
08/05/2009EP2083804A2 Compounds and methods for the modulation of toll-like receptor function
08/05/2009EP2083803A2 Formulations of active principles incorporated in slns suitable for transdermal administration
08/05/2009EP2083625A2 Bicyclic heteroaromatic compounds
08/05/2009EP2083624A2 2-hydroxy-2-phenyl/thiophenyl propionamides as androgen receptor modulators
08/05/2009EP2083623A1 Substituted imidazoles as bombesin receptor subtype-3 modulators
08/05/2009EP2083621A2 Modulators of amyloid-beta production
08/05/2009EP2061436B1 Ibuprofen-effervescent preparation having a high dissolution rate and method for the production thereof
08/05/2009EP2029559B1 Aryl-4-ethynyl-isoxazole derivatives
08/05/2009EP2012801A4 Gemcitabine combination therapy
08/05/2009EP1963270B1 Quaternary 3 -amido, n-methylpyridinium salts as anti -inflammatory agents
08/05/2009EP1957676A4 Gene expression profiling in primary ovarian serous papillary tumors and normal ovarian epithelium
08/05/2009EP1948132B1 Zolpidem tablets
08/05/2009EP1940772B1 Novel method for preparing quaternary acid and ammonium salts
08/05/2009EP1933759A4 Methods of administering rapamycin analogs with anti-inflammatories using medical devices
08/05/2009EP1931349A4 Use of sodium channel blockers for the management of musculoskeletal pain
08/05/2009EP1924560B1 6-substituted- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
08/05/2009EP1919474B1 Pyrrolopyridine derivatives and use of same as ppar receptor modulators
08/05/2009EP1888541B1 Benzo(d)isoxazol-3-yl-amine compounds and their use as vanilloid receptor ligands
08/05/2009EP1877398B1 Quinazoline derivatives as egf and/or erbb2 tyrosine kinase inhibitors
08/05/2009EP1877397B1 Quinazoline derivatives as inhibitors of egf and/or erbb2 receptor tyrosine kinase
08/05/2009EP1858512A4 Methods of treating cancer using ppar-gamma antagonists
08/05/2009EP1789039A4 S-triazolyl alpha -mercaptoacetanildes as inhibitors of hiv reverse transcriptase
08/05/2009EP1781606B1 Azetidine derivatives as ccr-3 receptor antagonists
08/05/2009EP1771458B1 N-phenylphosphoric acid triamides, method for the production thereof and their use as agents for regulating or inhibiting enzymatic urea hydrolysis
08/05/2009EP1771178B1 Use of k-252a and kinase inhibitors for the prevention or treatment of hmgb1-associated pathologies
08/05/2009EP1765786A4 An improved process for the preparation of oxcarbazepine and related intermediates
08/05/2009EP1765309B1 Smokeless toabacco product
08/05/2009EP1753721B1 Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems
08/05/2009EP1748783A4 Treatment or prevention of respiratory viral infections with immunomodulator compounds
08/05/2009EP1745010B1 Substituted cyclohexyl-1,4-diamine derivatives
08/05/2009EP1744774A4 Nutritional composition which promotes weight loss, burns calories, increases thermogenesis, supports energy metabolism and/or suppresses appetite
08/05/2009EP1742707A4 Treatment of cns disorders using cns target modulators
08/05/2009EP1737876B1 Avermectin and avermectin monosaccharide substituted in the 4"-and 4'-position respectively
08/05/2009EP1737821B1 3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis c virus ns3 serine protease
08/05/2009EP1737459B1 Imidazopyridine and imidazopyrimidine derivatives as antibacterial agents
08/05/2009EP1733012A4 A composition enriched in diglyceride with conjugated linoleic acid
08/05/2009EP1713803B1 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
08/05/2009EP1699454B1 Pyrazole derivatives and use thereof as orexin receptor antagonists
08/05/2009EP1680106B1 Combination treatment of obesity involving 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity and lipase inhibitors
08/05/2009EP1663957B1 Process of hydrocyanation of unsaturated carboxylic acid derivatives
08/05/2009EP1660507B1 Proteasome inhibitors and methods of using the same
08/05/2009EP1641457B1 Pyrrolo-dihydroisoquinoline derivatives as pde10 inhibitors
08/05/2009EP1635799B1 Pharmaceutical formulations of amyloid inhibiting compounds
08/05/2009EP1631292B1 4-anilino-quinazoline derivatives as antiproliferative agents
08/05/2009EP1622586B1 Process for preparing tannate tablet capsule or other solid dosage forms
08/05/2009EP1560837B1 Novel ampiphilic derivatives of alpha-c-phenyl n-tert-butyl nitrone
08/05/2009EP1531822B1 1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders
08/05/2009EP1531803A4 Method of inhibiting prostate cancer cell proliferation
08/05/2009EP1509506B1 Pyridazine derivatives
08/05/2009EP1503778B1 Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent
08/05/2009EP1501797B1 3-(substituted amino)-1h-indole-2-carboxylic acid ester and 3-(substituted amino)-benzo[b]thiophene-2-carboxylic acid ester derivatives as interleukin-4 gene expression inhibitors
08/05/2009EP1496052B1 Novel aminobenzamide derivative
08/05/2009EP1491534B1 Novel hairpin polyamide
08/05/2009EP1473289B1 Preventives or remedies for alzheimer's disease or amyloid protein fibrosis inhibitors containing nitrogen-containing heteroaryl compounds
08/05/2009EP1465880B1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use to treat disorders associated with somatostatine
08/05/2009EP1461313B1 Human adam-10 inhibitors
08/05/2009EP1445253B1 4,4-difluoro-1, 2, 3, 4-tetrahydro-5h-1-benzazepine derivatives or salts thereof
08/05/2009EP1430040B1 Benzothiazepine derivatives
08/05/2009EP1416923B1 Reduction of hair growth
08/05/2009EP1401825B1 Thiophene derivatives as antiviral agents for flavivirus infection
08/05/2009EP1399445B1 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists
08/05/2009EP1383731B1 Biaryl compounds as serine protease inhibitors
08/05/2009EP1357111B1 2-pyridone derivatives having affinity for cannabinoid type 2 receptor
08/05/2009EP1341786B9 Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
08/05/2009EP1296974B1 2-cyanopyrrolidine derivatives and their use as medicaments
08/05/2009EP1286662A4 Tablets and methods for modified release of hydrophilic and other active agents
08/05/2009EP1274402B1 Pharmaceutical composition for the controlled release of paracetamol
08/05/2009EP1249233B9 Npyy5 antagonists
08/05/2009EP1246913B1 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes
08/05/2009EP1235595B1 Integrin-mediated drug targeting
08/05/2009EP1210115B1 DOSAGES FOR TREATMENT WITH ANTI-ErbB2 ANTIBODIES
1 ... 2634 2635 2636 2637 2638 2639 2640 2641 2642 2643 2644 2645 2646 2647 2648 2649 2650 2651 2652 2653 2654 ... 7860